Biomedical subjects

V R Panz

Publications and source records attributed to V R Panz.

39 records · Page 3Linked to original sources

PubMedDate not supplied

Changes in glucose disposal and cellular insulin binding in obese black Southern African patients with type 2 diabetes mellitus before and after sulphonylurea therapy.

Peripheral insulin action and cellular insulin binding were studied in 10 newly detected, obese, black, Southern African women with Type 2 diabetes mellitus before and after mid-term oral sulphonylurea therapy and in five obese, non-diabetic controls. Glucose disposal (assessed by the euglycaemic insulin clamp technique) was significantly reduced in diabetic patients compared to control subjects (4.4 +/- 0.5 vs 6.4 +/- 0.5 mg kg-1 min-1, p < 0.05), and increased after 1 and 3 months of sulphonylurea therapy to 6.8 +/- 0.6 mg kg-1 min-1 (p = 0.01) and 6.3 +/- 0.7 mg kg-1 min-1 (p = 0.04), respectively. The major change in the binding kinetics of insulin to peripheral monocytes was an increase in the mean receptor concentration in the diabetic patients which was significant after 3 months of therapy (0.2 +/- 0.08 to 0.6 +/- 0.01 nM, p = 0.05). The basal plasma C-peptide concentration was significantly lower in the diabetic patients than in the controls and remained so following sulphonylurea therapy, despite significant reductions in fasting glucose and HbA1 concentrations. We conclude that newly diagnosed, obese, black Southern Africans with Type 2 diabetes showed diminished peripheral glucose disposal which increased following sulphonylurea therapy. This was accompanied by an increase in insulin receptor concentration but not with changes in basal insulin secretion.

Adult↗

PubMedDate not supplied

Performance of the CardioChek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids.

Point-of-care (POC) blood testing is intended to provide results more rapidly than can be obtained from a central laboratory. Precision and accuracy of the CardioChek PA and Cholestech LDX analysers were compared to clinical diagnostic laboratory methods. In 100 patients, total cholesterol (TC), triglycerides (TG), HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) levels were measured by both analysers and compared to those analysed by the National Health Laboratory Service (NHLS) laboratory. Data were evaluated for conformance with National Cholesterol Education Program (NCEP) guidelines. Results were grouped into low, middle and high ranges and were similar to those obtained by the NHLS, except in the high range where TC and LDL-C levels were under-read by both analysers. All analytes measured by both analysers correlated significantly with NHLS (p < 0.0001). With the exception of LDL-C, both analysers showed reasonable compliance with NCEP goals for coefficients of variation and bias measurements. Both analysers met NCEP guidelines for all analytes at two clinical cut-off points. We concluded that, compared to NHLS methods, performance of the CardioChek PA and Cholestech LDX analysers is acceptable and that they offer healthcare professionals a rapid, POC method for the measurement of lipids.

Biomarkers↗

PubMedDate not supplied

Metabolic syndrome, undiagnosed diabetes mellitus and insulin resistance are highly prevalent in urbanised South African blacks with coronary artery disease.

BACKGROUND: The prevalence of coronary artery disease (CAD) is low in South African blacks, despite increasing westernisation and the accompanying rise in risk factors that are common to CAD and the metabolic syndrome (MS). AIM: To assess the prevalence of the MS and abnormal glucose regulation in black patients with established CAD, who had no previously known diabetes mellitus (DM). METHODS: In 40 patients, anthropometric and biochemical variables were measured by standard methods. MS risk factors were analysed according to the National Cholesterol Education Program Adult Treatment Panel III guidelines. Glucose regulation was assessed by the oral glucose tolerance test, and insulin resistance was evaluated using the hyperinsulinaemic euglycaemic clamp technique (M-value). RESULTS: MS was present in 24 patients (60%) and absent in 16 patients (40%). Abdominal obesity, measured as increased waist circumference (WC), was the risk factor that differentiated the two groups and, together with hypertension and elevated glucose, formed the most frequent risk-factor combination. No significant differences were found in the proportions of males or females above and below the various cut-off points for gender-associated risk factors (WC and HDL cholesterol). There was a significant correlation between WC and M-value (r = -0.3595; p = 0.02). Half the patients had abnormal glucose regulation, comprising impaired glucose tolerance (IGT) in 30% and DM in 20% of the patient cohort. CONCLUSIONS: MS was highly prevalent in our black patients with CAD. Increased WC was the most important risk factor and, together with hypertension and elevated glucose, formed the most frequent risk-factor combination. Abdominal obesity was significantly related to insulin resistance. Previously undiagnosed impaired glucose tolerance (IGT) and DM were common abnormalities.

Black People↗